lost weight

Nearly 40% of individuals regaining weight after discontinuing GLP-1 receptor agonists experienced a significantly elevated risk of major adverse cardiovascular events (MACE) – heart attack, stroke, or death – according to recent studies. This startling statistic underscores a critical shift in how we view these drugs: they aren’t simply weight-loss tools, but potentially vital cardiovascular … Read more